comparison between aspirin and placebo on the mean of 24 hour blood pressure in pregnant women at preeclampsia risk, a double blind randomized controlled clinical trial
Authors
abstract
background gestational hypertension is one of the three common causes of maternal death. this study was designed to compare the effects of aspirin and placebo on 24 hour blood pressure mean in women at risk of preeclampsia in two different diurnal times to prevent preeclampsia. methods sixty four women who were at risk of gestational hypertension were recruited to be included in the study using convenience sampling method and divided into 4 groups by random allocation. control groups one and two received placebo tablet. experimental groups one and two received aspirin tablets (100 mg) in the morning and at night, respectively , one tablet a day every day starting at the time of recruitment and continued till 32nd week of gestation, by double blind method. the patients’ blood pressure was monitored at the end of each month for 24 consecutive hours from 12 to16 weeks until delivery. data were analyzed using repeated measures design and along with multiple comparative tests in spss software (version 8.0). results in aspirin and control group 1, systolic and diastolic bp mean variations were similar, (p=0.835 and p=0.705 for systole and diastole, respectively). in aspirin and control group 2, systolic and diastolic bp mean variations were statistically significant. (for systole and diastole p<0.001). mean reduction for systole was 14.12 mmhg in 32nd week and 12.12 mmhg in 40th week and for diastole it was 11.69 mmhg in 32nd week and 9.04 mmhg in 40th week. conclusion taking aspirin at night is more effective on 24-hour blood pressure mean reduction in women at preeclampsia risk compared with that in the morning. trial registration number: irct138803211548n5
similar resources
The effect of aspirin on preeclampsia and fetal growth restriction (FGR) in obese pregnant women : a randomized controlled clinical trial
Background: To evaluate the effect of aspirin on preeclampsia and fetal growth restriction (FGR) in obese pregnant women. Methods: A randomized clinical trial with 187 participants. Participants were allocated to either an intervention (aspirin; n=89) or control (placebo; n=98) group. In two groups, intervention was done from 13-20 until 34 weeks of pregnancy. Outcomes were preeclampsia and FG...
full textComparison between Golnar product and placebo in heavy menstrual bleeding: A double-blind randomized clinical trial
Objective: Golnar product is a poly herbal formulation advised by Persian medicine to control heavy menstrual bleeding (HMB). This study was conducted to compare the efficacy of this product with placebo in patients with HMB. Materials and Methods: In this double-blind randomized clinical trial, 100 women with HMB were randomly assigned into two groups. T...
full textSelenium supplementation and the incidence of preeclampsia in pregnant Iranian women: a randomized, double-blind, placebo-controlled pilot trial.
OBJECTIVE Recent studies have reported that antioxidant status, including serum selenium concentrations, is altered in women who develop preeclampsia. We wished to examine the effects of selenium supplementation in the prevention of preeclampsia in high-risk pregnant women. DESIGN We carried out a randomized, double-blind, placebo-controlled pilot trial. A total of 166 primigravid pregnant wo...
full textEfficacy and safety of bupropion in quality of life of cancer patients, a randomized double blind placebo controlled clinical trial
Background and purpose: Decreasing the quality of life in cancer patients is an essential factor that influences their lives during the process of treatment and after that. A lot of studies have been done to evaluate the efficacy of medical agents on quality of life. In this study, we evaluate the efficacy of Bupropion as an antidepressant agent in quality of life of cancer patients. Materials...
full textgastrointestinal complications of ferrous sulfate in pregnant women: a randomized double-blind placebo-controlled trial
conclusions it can be concluded that gi complications in pregnant women using ferrous sulfate are mostly caused by physiologic changes of pregnancy rather than ferrous sulfate; therefore, it is not reasonable to stop using ferrous sulfate due to gi complications. results none of the gi complications were significantly different between the ferrous sulfate and placebo groups at 24th - 28th and 3...
full textMethoxsalen bath in the treatment of palmoplantar Eczema: A double-blind, placebo controlled clinical trial
Background: Palmoplantar eczema is a common clinical problem involving 2% of the population. There are many treatment modalities for palmoplantar eczema, each with specific local and systemic side effects. Objective: To evaluate methoxsalen bath in the treatment of palmoplantar eczema. Patients and Methods: In a randomized, double-blind, placebo controlled clinical trial, 60 patients with palmo...
full textMy Resources
Save resource for easier access later
Journal title:
international journal of community based nursing and midwiferyجلد ۱، شماره ۲، صفحات ۸۳-۰
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023